Evidence map›Paper›PMID 34663186›Full record

ArticleEmerging microbes & infections2021

Real-time monitoring of

Miglė Žiemytė, Miguel Carda-Diéguez, Juan C Rodríguez-Díaz, Maria P Ventero, Alex Mira, María D Ferrer

Open access · goldAbstract read
In one paragraph

Article in Emerging microbes & infections, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Review
  3. UnderstandingMicroorganisms · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. mBio · 2024
    Article
  10. Article
  11. Microbiology spectrum · 2024
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Recent Advances in Bacterial Persistence Mechanisms.International journal of molecular sciences · 2023
    Review
  17. Genome Analysis ofPathogens (Basel, Switzerland) · 2023
    Article
  18. Frontiers in cellular and infection microbiology · 2023
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Miglė ŽiemytėGenomics & Health Department, FISABIO Foundation, Valencia, Spain.ORCID 0000-0001-5965-3928
Miguel Carda-DiéguezGenomics & Health Department, FISABIO Foundation, Valencia, Spain.ORCID 0000-0002-9566-0321
Juan C Rodríguez-DíazServicio de Microbiología, Hospital General Universitario de Alicante, ISABIAL, Alicante, Spain.ORCID 0000-0001-8007-5739
Maria P VenteroServicio de Microbiología, Hospital General Universitario de Alicante, ISABIAL, Alicante, Spain.ORCID 0000-0003-1979-0949
Alex MiraGenomics & Health Department, FISABIO Foundation, Valencia, Spain.ORCID 0000-0002-9127-3877
María D FerrerGenomics & Health Department, FISABIO Foundation, Valencia, Spain.ORCID 0000-0002-4521-1632
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital General Universitario de Alicante Doctor Balmis · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm formation and the appearance of persister cells with low metabolic rates are key factors affecting conventional treatment failure and antibiotic resistance. Using impedance-based measurements, crystal violet staining and traditional culture we have studied the biofilm growth dynamics of 13

Indexed as

BiofilmsAnti-Bacterial AgentsCiprofloxacinHumansMicrobial Sensitivity TestsMicrobial ViabilityMutationPolymorphism, Single NucleotidePseudomonas aeruginosaPseudomonas InfectionsStaining and LabelingAnti-Bacterial AgentsCiprofloxacinantibiotic resistancebiofilmsciprofloxacinmannitolP. aeruginosapersister cellsxCELLigence

Identifiers

PMID34663186
PMCPMC8583918
OpenAlexW3207324324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.